Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-13 Sale | 2025-06-17 4:11 pm | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 12,255 | $2.7239 | $33,381 | 226,271 (Direct) | View |
| 2025-06-16 Sale | 2025-06-17 4:10 pm | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 13,884 | $2.689 | $37,334 | 272,252 (Direct) | View |
| 2025-06-16 Sale | 2025-06-17 4:09 pm | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 55,511 | $2.6889 | $149,264 | 1,182,842 (Indirect Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:34 pm | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 37,656 | $0.599 | $22,556 | 1,088,353 (Indirect Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:33 pm | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 8,551 | $0.599 | $5,122 | 201,026 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:32 pm | CytomX Therapeutics Inc. | CTMX | Chu Yu-Waye Chief Medical Officer | 4,025 | $0.599 | $2,411 | 135,725 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:32 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 10,203 | $0.599 | $6,112 | 120,594 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 4:31 pm | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 19,512 | $0.599 | $11,688 | 248,636 (Direct) | View |
| 2024-08-20 Sale | 2024-08-22 6:01 pm | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 4,181 | $1.2291 | $5,139 | 126,736 (Indirect Direct) | View |
| 2024-08-20 Sale | 2024-08-22 6:01 pm | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 4,181 | $1.2291 | $5,139 | 175,648 (Direct) | View |
| 2024-08-20 Sale | 2024-08-22 6:00 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 4,181 | $1.2291 | $5,139 | 130,797 (Direct) | View |
| 2024-08-20 Sale | 2024-08-22 5:59 pm | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 1,984 | $1.2291 | $2,439 | 108,077 (Direct) | View |
| 2024-08-20 Sale | 2024-08-22 5:58 pm | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 13,898 | $1.2291 | $17,082 | 751,009 (Indirect Direct) | View |
| 2024-03-19 Sale | 2024-03-21 4:41 pm | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 5,268 | $2.0855 | $10,986 | 117,728 (Direct) | View |
| 2024-03-19 Sale | 2024-03-21 4:40 pm | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 20,223 | $2.0855 | $42,175 | 617,639 (Indirect Direct) | View |
| 2024-03-19 Sale | 2024-03-21 4:38 pm | CytomX Therapeutics Inc. | CTMX | Ogden Christopher SVP, Finance and Accounting | 2,971 | $2.0855 | $6,196 | 85,686 (Direct) | View |
| 2024-03-19 Sale | 2024-03-21 4:37 pm | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 12,795 | $2.0855 | $26,684 | 168,579 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-13 Exercise | 2025-06-17 4:11 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 37,500 | $0 | 226,271 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-17 4:10 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 37,500 | $0 | 272,252 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-17 4:09 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 150,000 | $0 | 1,182,842 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:19 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Su Zhen Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:18 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Young Matthew P. Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:18 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Mohindru Mani Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:17 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:17 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Jones Elaine V Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:16 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Gilbert Halley E Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 4:16 pm | N/A 2035-06-10 | CytomX Therapeutics Inc. | CTMX | Ashworth Alan Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2025-02-04 Option Award(A) | 2025-02-10 5:58 pm | N/A 2035-02-03 | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 357,500 | $0 | 533,148 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 5:57 pm | N/A 2035-02-03 | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 342,500 | $0 | 518,148 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 5:55 pm | N/A 2035-02-03 | CytomX Therapeutics Inc. | CTMX | Chu Yu-Waye Chief Medical Officer | 466,500 | $0 | 492,750 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 5:55 pm | N/A 2035-02-03 | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 441,500 | $0 | 549,577 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 5:54 pm | N/A 2035-02-03 | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 1,565,000 | $0 | 2,316,009 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-22 6:01 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 11,250 | $0 | 126,736 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-22 6:01 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | BELVIN MARCIA SVP, Chief Scientific Officer | 11,250 | $0 | 175,648 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-22 6:00 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | ROWLAND LLOYD A General Counsel | 11,250 | $0 | 130,797 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-22 5:59 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 6,875 | $0 | 108,077 (Direct) | View |
| 2024-08-20 Exercise | 2024-08-22 5:58 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 37,500 | $0 | 751,009 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 4:24 pm | N/A 2034-06-11 | CytomX Therapeutics Inc. | CTMX | Ogden Christopher Chief Financial Officer | 92,500 | $0 | 178,186 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:36 pm | N/A 2034-05-14 | CytomX Therapeutics Inc. | CTMX | Young Matthew P. Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:36 pm | N/A 2034-05-14 | CytomX Therapeutics Inc. | CTMX | Su Zhen Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:34 pm | N/A 2034-05-14 | CytomX Therapeutics Inc. | CTMX | Mohindru Mani Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:34 pm | N/A 2034-05-14 | CytomX Therapeutics Inc. | CTMX | Meyers James R Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:33 pm | N/A 2034-05-14 | CytomX Therapeutics Inc. | CTMX | Jones Elaine V Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:32 pm | N/A 2034-05-14 | CytomX Therapeutics Inc. | CTMX | Gilbert Halley E Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-05-15 Option Award | 2024-05-17 5:31 pm | N/A 2034-05-14 | CytomX Therapeutics Inc. | CTMX | Ashworth Alan Director | 38,000 | $0 | 38,000 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-28 7:12 pm | N/A 2025-02-08 | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 109,768 | $0 | 727,407 (Direct) | View |
| 2024-03-26 Exercise | 2024-03-28 7:12 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | McCarthy Sean A. CEO | 109,768 | $1.5749 | 727,407 (Direct) | View |
| 2024-03-20 Option Award | 2024-03-22 4:27 pm | N/A 2034-03-19 | CytomX Therapeutics Inc. | CTMX | Su Zhen Director | 76,000 | $0 | 76,000 (Direct) | View |